The investment seeks to provide long-term growth of capital. The fund typically invests at least 80% of assets in securities of companies in health science and related industries. It invests more than 25% of assets in health sciences or related industries, and may invest in companies located in non-U.S. countries. The fund also may invest up to 20% of total assets in other securities. It may invest without limit in shares of companies through initial public offerings (IPOs). The fund is nondiversified.
0.22 (0.86%) 